The 12 closest competitors and alternatives to Cogitat among healthtech companies — ranked by similarity to what Cogitat actually does, not by market-cap band.
Subscribe to see Cogitat’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cogitat Ltd is a biotechnology research and neurotechnology company headquartered in Royston, United Kingdom, and founded as an Imperial College London spin-out. The company develops AI-driven, non-invasive brain-computer interface technology that allows users to control computing systems.
Cogitat is a healthtech company headquartered in United Kingdom, founded in 2020. Xcout tracks 6 named people at Cogitat, including Allan Ponniah (Cofounder - CEO).
Ranked by semantic similarity — how close each company is to Cogitat by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthtech company
CoMind is a health technology company working at the interface of optics, engineering, and neuroscience with a vision to enhance brain health and redefine how the brain is measured.
Medical Technology
Neuro-Vascular Research & Design Corp develops artificial intelligence-powered intraoperative neuromonitoring (IONM) platforms and precision hardware for surgical environments. The company's technology provides real-time data analysis to help healthcare providers detect neurological risks and guide surgical decision-making during high-risk surgeries.
Enterprise Systems (Healthcare)
Inner Cosmos Inc. is a neurotechnology company located in Fort Lauderdale, Florida, developing a drug-free, home-based brain-computer interface treatment for depression and cognitive disorders.
Mental Health Care
Mind-X Corp. is a software development company located in Bethesda, Maryland, focused on neurotechnology and related brain-computer applications before its acquisition by Blackrock Neurotech.
Healthcare
Neurophet is a software development and medical technology company headquartered in Seoul, South Korea, that specializes in AI-powered solutions for diagnosing, treating, and guiding care for brain disorders.
Healthcare
Neural Galaxy is a brain science and life sciences company founded in 2019 that originated from Harvard Medical School and the Massachusetts Institute of Technology. The company develops advanced software and hardware technologies for brain functional mapping and non-invasive neuromodulation to address brain disorders. Additionally, it aims to build a research platform to promote basic and applied brain science research.
Health
WIVI Vision is an innovative health technology company headquartered in Barcelona, Spain, that focuses on visual health solutions and cognitive vision assessment and training.
Health
NeoSensory, Inc. was founded in 2015 and is headquartered in California, specializing in creating sensory technology that addresses hearing impairments.
Biotechnology / Healthcare Technology
Cumulus Neuroscience is a UK neurotechnology company that develops wearable EEG headsets and associated software for measuring brain activity and cognitive function. Its products are intended primarily for pharmaceutical and biotechnology companies conducting clinical trials and developing treatments for neurological and psychiatric disorders.
Similar healthtech company
Cambridge Cognition Holdings Plc is a neuroscience technology company focused on developing and globally marketing sophisticated cognitive testing solutions for use in clinical settings. The firm operates internationally, serving clients in the United States, United Kingdom, and European Union, among other regions. Its extensive product portfolio includes CANTAB Recruit, an online platform designed to help pharmaceutical and biotechnology companies efficiently identify and onboard eligible participants for clinical trials, particularly in high-need therapeutic areas such as Alzheimer's disease. For broader pharmaceutical research, CANTAB Connect offers digital cognitive assessment tools applicable across all clinical trial phases (I-IV) and various medical fields. Additionally, the Cognition Kit is a digital health platform that utilizes wearable and smartphone applications to collect data, aiming to boost patient involvement, validate treatment efficacy, and deepen understanding of diseases and individual responses to medication. Other specialized offerings include CANTAB Connect Research, advanced software providing precise digital metrics for cognitive function in brain research; CANTAB Mobile, a touchscreen memory test frequently used in clinical studies pertaining to Alzheimer's disease; and CANTAB BrainHealth, an online digital assessment tool for monitoring mental well-being and cognitive performance in professional environments. The company also provides CANTAB Insight, a medical device for evaluating an individual's cognitive health, and NeuroVocalix, a secure platform enabling automated administration and scoring of validated verbal cognitive assessments. Beyond its technological products, Cambridge Cognition furnishes a suite of expert consultancy and operational management services tailored to enhance clinical trials and cognitive research. These services encompass neuroscience and technical advice, study design, data analysis, comprehensive study and data management, and the provision of insightful reports and interpretations. Cambridge Cognition Holdings Plc was established in 2012 and is headquartered in Cambridge, United Kingdom.
Healthcare Technology
CereGate is a medical technology company headquartered in Munich, Germany, focusing on the treatment of neurological disorders. The company develops innovative, minimally invasive Computer-Brain Interface (CBI) technology to improve patient care.
Similar healthtech company
Melbourne, Australia-based Cogstate Limited, established in 1999, is a neuroscience technology company specializing in computerized cognitive assessments and digital solutions for clinical outcome evaluations. Its comprehensive suite of cognitive services includes project and data management, scientific consulting, statistical analysis, procurement of assessment scales, rater training, and monitoring solutions. The company operates through two distinct divisions. The Clinical Trials segment delivers technology and support services designed to measure the impact of diseases, pharmaceuticals, medical devices, or other interventions on human participants in clinical studies, primarily serving pharmaceutical and biotechnology clients. Concurrently, its Healthcare segment offers Cognigram, a system facilitating regular and standardized testing to assist primary care physicians and hospitals in the early identification of cognitive decline. By June 30, 2022, Cogstate had participated in an estimated 1,800 academic research initiatives.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Cogitatand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →